Explore
13D/13G Activist Filings
119,210 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | N/A | Coatue Innovative Strategies Fund | Philippe Laffont | 13G/A | 3.5% | 7.3M |
| Nov 14, 2025 | SVRA | Savara Inc | Growth Equity Opportunities 17, LLC | 13D/A | 12.0% | 24.5M |
| Nov 14, 2025 | CNTX | Context Therapeutics Inc. | Avidity Partners Management LP | 13G/A | 9.9% | 9.2M |
| Nov 14, 2025 | EVH | Evolent Health, Inc. | Durable Capital Partners LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | VRNA | Verona Pharma plc | Pentwater Capital Management LP | 13G | 0.0% | 0 |
| Nov 14, 2025 | UPB | Upstream Bio, Inc. | TCG Crossover GP I, LLC | 13G/A | 3.9% | 2.1M |
| Nov 14, 2025 | PSBD | Palmer Square Capital BDC Inc | First Trust Capital Management L.P. | 13G/A | 4.0% | 1.3M |
| Nov 14, 2025 | YOU | Clear Secure, Inc. | Durable Capital Partners LP | 13G/A | 6.7% | 6.4M |
| Nov 14, 2025 | ZYME | Zymeworks Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 2.7% | 2.0M |
| Nov 14, 2025 | AMC | AMC ENTERTAINMENT HOLDINGS, INC. | Pentwater Capital Management LP | 13G | 9.5% | 48.6M |
| Nov 14, 2025 | COGT | Cogent Biosciences, Inc. | TCG Crossover GP I, LLC | 13G/A | 4.8% | 6.8M |
| Nov 14, 2025 | CBZ | CBIZ, Inc. | Durable Capital Partners LP | 13G/A | 7.3% | 3.9M |
| Nov 14, 2025 | CORZ | Core Scientific, Inc./tx | Pentwater Capital Management LP | 13G | 8.5% | 26.1M |
| Nov 14, 2025 | IMTX | Immatics N.V. | Baker Bros. Advisors LP | 13G/A | 9.9% | 12.1M |
| Nov 14, 2025 | GTERA | Globa Terra Acquisition Corp | Globa Terra Management LLC | 13G | 19.8% | 4.6M |
| Nov 14, 2025 | CPHC | Canterbury Park Holding Corp | Black Diamond Capital Management I, LLLP | 13G/A | 16.8% | 859K |
| Nov 14, 2025 | RAC | Rithm Acquisition Corp. | Meteora Capital, LLC | 13G | 7.2% | 1.7M |
| Nov 14, 2025 | ETHZ | ETHZilla Corp | STEADFAST CAPITAL MANAGEMENT LP | 13G/A | 4.5% | 7.2M |
| Nov 14, 2025 | ETNB | 89bio, Inc. | Pentwater Capital Management LP | 13G | 0.0% | 0 |
| Nov 14, 2025 | SABS | SAB Biotherapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 6.1% | 3.0M |
| Nov 14, 2025 | CERS | Cerus Corporation | Baker Bros. Advisors LP | 13G/A | 5.2% | 10.0M |
| Nov 14, 2025 | CFND | C1 Fund Inc. | STEADFAST CAPITAL MANAGEMENT LP | 13G/A | 1.4% | 399K |
| Nov 14, 2025 | TNGX | Tango Therapeutics, Inc. | TCG Crossover GP II, LLC | 13G/A | 6.3% | 8.5M |
| Nov 14, 2025 | TV | GRUPO TELEVISA, S.A.B. | Eduardo Tricio Haro | 13D | 7.7% | 24.1B |
| Nov 14, 2025 | LMFA | LM FUNDING AMERICA, INC. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 5.0% | 817K |
| Nov 14, 2025 | CYBR | CyberArk Software Ltd. | Pentwater Capital Management LP | 13G | 7.3% | 3.7M |
| Nov 14, 2025 | GSM | Ferroglobe PLC | COOPER CREEK PARTNERS MANAGEMENT LLC | 13G/A | 7.9% | 14.8M |
| Nov 14, 2025 | NKTR | Nektar Therapeutics, Inc. | TCG Crossover GP II, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CDTX | Cidara Therapeutics, Inc. | TCG Crossover GP II, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | ASST | Asset Entities Inc. | STEADFAST CAPITAL MANAGEMENT LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | ABVX | Abivax SA | TCG Crossover GP I, LLC | 13G/A | 8.3% | 6.5M |
| Nov 14, 2025 | CETX | CEMTREX INC | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.9% | 7K |
| Nov 14, 2025 | NSPR | InspireMD, Inc. | MARSHALL WACE, LLP | 13G/A | 10.0% | 28.1M |
| Nov 14, 2025 | SGRY | Surgery Partners, Inc. | Pentwater Capital Management LP | 13G/A | 9.1% | 11.7M |
| Nov 14, 2025 | RAPT | RAPT Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NBR | Nabors Industries Ltd. | BRIGADE CAPITAL MANAGEMENT, LP | 13G/A | 4.7% | 741K |
| Nov 14, 2025 | AMED | AMEDISYS INC | Pentwater Capital Management LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | NIQ | NIQ Global Intelligence plc | ADVENT INTERNATIONAL, L.P. | 13G | 55.1% | 162.6M |
| Nov 14, 2025 | BXC | BlueLinx Holdings Inc. | Tontine Asset Associates, LLC | 13G/A | 5.7% | 449K |
| Nov 14, 2025 | SKX | SKECHERS USA INC | Pentwater Capital Management LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | UNCY | Unicycive Therapeutics, Inc. | RA Capital Management, L.P. | 13G/A | 9.9% | 2.0M |
| Nov 14, 2025 | EWCZ | European Wax Center, Inc. | Ararat Capital Management, LP | 13G/A | 7.2% | 3.1M |
| Nov 14, 2025 | DRIO | DarioHealth Corp. | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 13G/A | 4.6% | 316K |
| Nov 14, 2025 | JZXN | Jiuzi Holdings, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 8.0% | 4.0M |
| Nov 14, 2025 | PVLA | PALVELLA THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 5.4% | 634K |
| Nov 14, 2025 | ONCH | 1RT Acquisition Corp. | Jain Global LLC | 13G | 5.2% | 894K |
| Nov 14, 2025 | HLVX | HilleVax, Inc. | EcoR1 Capital, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | ATRA | Atara Biotherapeutics, Inc. | Redmile Group, LLC | 13D/A | 9.9% | 751K |
| Nov 14, 2025 | TRML | TOURMALINE BIO, INC. | RA Capital Management, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | SND | Smart Sand, Inc. | Tontine Asset Associates, LLC | 13G/A | 6.1% | 2.7M |